Vedanta Biosciences Closes $50 Million Financing to Advance Microbiome Therapeutics

The funding will accelerate infectious and autoimmune disease programs to the clinic and support scale up of the company’s technology platform

CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--Vedanta Biosciences, pioneering the development of a... Biopharmaceuticals, Venture CapitalVedanta Biosciences, microbiome

Source: HSMN NewsFeed - June 6, 2016 Category: Pharmaceuticals Source Type: news